Curocell Completes Korea’s First Phase 2 Clinical Trial for Next-Generation CAR-T

Posted on by

Anbal-cel argeting DLBCL completes phase 2 trial Anticipation growing over Korea’s first CAR-T therapy ahead of regulatory review Commercial manufacturing scheduled in 2025 at Korea’s only CAR-T GMP facility DAEJEON, South Korea, Nov. 1, 2023 /PRNewswire/ — Curocell, South Korea based…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.